Movano Inc. (NASDAQ:MOVE – Get Free Report)’s stock price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $7.27 and traded as high as $10.60. Movano shares last traded at $8.99, with a volume of 60,416 shares.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Movano in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company has an average rating of “Sell”.
Check Out Our Latest Report on MOVE
Movano Trading Down 14.4%
Movano (NASDAQ:MOVE – Get Free Report) last posted its quarterly earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share for the quarter, topping the consensus estimate of ($7.00) by $2.27. Movano had a negative net margin of 3,409.60% and a negative return on equity of 647.91%. The business had revenue of $0.08 million during the quarter, compared to the consensus estimate of $3.88 million.
Hedge Funds Weigh In On Movano
Several institutional investors and hedge funds have recently bought and sold shares of MOVE. Citadel Advisors LLC purchased a new position in Movano in the 3rd quarter worth approximately $28,000. Clayton Partners LLC boosted its stake in shares of Movano by 27.2% during the first quarter. Clayton Partners LLC now owns 143,476 shares of the technology company’s stock valued at $263,000 after purchasing an additional 30,708 shares during the period. Finally, Baird Financial Group Inc. grew its holdings in shares of Movano by 3.6% in the first quarter. Baird Financial Group Inc. now owns 323,943 shares of the technology company’s stock worth $593,000 after purchasing an additional 11,366 shares during the last quarter. 16.64% of the stock is currently owned by institutional investors.
Movano Company Profile
Movano Inc engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking.
Featured Articles
- Five stocks we like better than Movano
- The Most Important Warren Buffett Stock for Investors: His Own
- Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity
- What is the Hang Seng index?
- Congress Beat the Market Again—Here Are the 3 Stocks They Bought
- Trading Halts Explained
- Go on a Shopping Spree With 3 Top Retail ETFs
Receive News & Ratings for Movano Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Movano and related companies with MarketBeat.com's FREE daily email newsletter.
